The Division of Hematologic Malignancies within MSK’s Department of Medicine is dedicated to treating patients with a variety of blood cancers, as well as some benign hematologic diseases. Our physicians and scientists are central players in advancing translational and clinical research and establishing the standard of care for patients with hematologic cancers.
The Division of Hematologic Malignancies includes the:
- Adult Bone Marrow Transplant Service
- Cellular Therapy Service
- Hematology Service
- Leukemia Service
- Lymphoma Service
- Myeloma Service